Literature DB >> 16787682

Gene amplification in cancer.

Donna G Albertson1.   

Abstract

Gene amplification is a copy number increase of a restricted region of a chromosome arm. It is prevalent in some tumors and is associated with overexpression of the amplified gene(s). Amplified DNA can be organized as extrachromosomal elements, as repeated units at a single locus or scattered throughout the genome. Common chromosomal fragile sites, defects in DNA replication or telomere dysfunction might promote amplification. Some regions of amplification are complex, yet elements of the pattern are reproduced in different tumor types. A genetic basis for amplification is suggested by its relative frequency in some tumor subtypes, and its occurrence in "early" preneoplastic lesions. Clinically, amplification has prognostic and diagnostic usefulness, and is a mechanism of acquired drug resistance.

Entities:  

Mesh:

Year:  2006        PMID: 16787682     DOI: 10.1016/j.tig.2006.06.007

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  195 in total

Review 1.  Regulation of DNA replication during development.

Authors:  Jared Nordman; Terry L Orr-Weaver
Journal:  Development       Date:  2012-02       Impact factor: 6.868

2.  Loss of DNA replication control is a potent inducer of gene amplification.

Authors:  Brian M Green; Kenneth J Finn; Joachim J Li
Journal:  Science       Date:  2010-08-20       Impact factor: 47.728

3.  High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications.

Authors:  Johan H Gibcus; Klaas Kok; Lorian Menkema; Mario A Hermsen; Mirjam Mastik; Philip M Kluin; Jacqueline E van der Wal; Ed Schuuring
Journal:  Hum Genet       Date:  2006-12-15       Impact factor: 4.132

4.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.

Authors:  Leonora Balaj; Ryan Lessard; Lixin Dai; Yoon-Jae Cho; Scott L Pomeroy; Xandra O Breakefield; Johan Skog
Journal:  Nat Commun       Date:  2011-02-01       Impact factor: 14.919

5.  Hypomethylation of the 14-3-3σ promoter leads to increased expression in non-small cell lung cancer.

Authors:  Vijayababu M Radhakrishnan; Taylor J Jensen; Haiyan Cui; Bernard W Futscher; Jesse D Martinez
Journal:  Genes Chromosomes Cancer       Date:  2011-07-13       Impact factor: 5.006

6.  Autophagy suppresses tumor progression by limiting chromosomal instability.

Authors:  Robin Mathew; Sameera Kongara; Brian Beaudoin; Cristina M Karp; Kevin Bray; Kurt Degenhardt; Guanghua Chen; Shengkan Jin; Eileen White
Journal:  Genes Dev       Date:  2007-05-17       Impact factor: 11.361

7.  Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.

Authors:  Madhav Sankunny; Rahul A Parikh; Dale W Lewis; William E Gooding; William S Saunders; Susanne M Gollin
Journal:  Genes Chromosomes Cancer       Date:  2013-11-25       Impact factor: 5.006

8.  Integrative molecular characterization of head and neck cancer cell model genomes.

Authors:  Ivy F L Tsui; Cathie Garnis
Journal:  Head Neck       Date:  2010-09       Impact factor: 3.147

9.  Inferring tumor progression from genomic heterogeneity.

Authors:  Nicholas Navin; Alexander Krasnitz; Linda Rodgers; Kerry Cook; Jennifer Meth; Jude Kendall; Michael Riggs; Yvonne Eberling; Jennifer Troge; Vladimir Grubor; Dan Levy; Pär Lundin; Susanne Månér; Anders Zetterberg; James Hicks; Michael Wigler
Journal:  Genome Res       Date:  2009-11-10       Impact factor: 9.043

10.  Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression.

Authors:  Andrzej B Popławski; Michał Jankowski; Stephen W Erickson; Teresita Díaz de Ståhl; E Christopher Partridge; Chiquito Crasto; Jingyu Guo; John Gibson; Uwe Menzel; Carl Eg Bruder; Aneta Kaczmarczyk; Magdalena Benetkiewicz; Robin Andersson; Johanna Sandgren; Barbara Zegarska; Dariusz Bała; Ewa Srutek; David B Allison; Arkadiusz Piotrowski; Wojciech Zegarski; Jan P Dumanski
Journal:  Eur J Hum Genet       Date:  2010-01-06       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.